Background illustration for clinical trials search

Paid Clinical Trials Denton

Discover 1,955 paid clinical trials in Denton, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Study of Individuals Affected With Hypoplasminogenemia

for
Plasminogen Deficiency
Location: Forth Worth TX, Birmingham AL, Indianapolis IN,
Sponsor: Indiana Hemophilia &Thrombosis Center, Inc.

Sex: All

Age: 0+

Code: NCT03797495

Recruiting

A Study of Investigational Agents in Participants With Previously Treated Stage IV Nonsquamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01H/KEYMAKER-U01)

for
Carcinoma, Non-Small-Cell Lung
Location: Dallas TX, Lexington KY, Pittsburgh PA, Baltimore MD
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06780085

Phase 2, Recruiting

A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

for
Ulcerative Colitis, Ulcerative Colitis Chronic,
Location: Fort Worth TX, St Louis MO, Atlanta GA, Toronto,
Sponsor: Eli Lilly and Company

Sex: All

Age: 2 - 19

Code: NCT04844606

Phase 3, Recruiting

Protocol for Collecting, Banking and Distributing Human Tissue Samples: St. Jude Children's Research Hospital Tissue Resources Core Facility

for
Normal and Diseased Tissue and Body Fluids Samples
Location: Fort Worth TX, Shreveport LA, Tulsa OK, Springfield MO,
Sponsor: St. Jude Children's Research Hospital

Sex: All

Age: 0+

Code: NCT01354002

Recruiting

Neuroblastoma Biology Study

for
Neuroblastoma
Location: Fort Worth TX, Aurora CO, Atlanta GA, Chicago IL,
Sponsor: New Approaches to Neuroblastoma Therapy Consortium

Sex: All

Age: 0 - 70+

Code: NCT01587300

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants

for
Crohns Disease, Colitis, Ulcerative, Arthritis, Psoriatic,
Location: Fort Worth TX, Atlanta GA, Indianapolis IN,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 3+

Code: NCT06663332

Phase 3, Recruiting

A Study to Evaluate the Pharmacokinetics and Safety of XEMBIFY Versus Gamunex-C in Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy

for
CIDP (Chronic Inflammatory Demyelinating Polyradiculoneuropathy),
Location: Sherman TX, Houston TX, Cordova TN, Port Charlotte FL,
Sponsor: Grifols Therapeutics LLC

Sex: All

Age: 18+

Code: NCT07540221

Phase 3, Recruiting

HOTSPOT Study: Implement and Evaluate the PrEP (Pre-exposure Prophylaxis) Implementation Strategy

for
PrEP, HIV, Incarceration
Location: Dallas TX
Sponsor: University of Texas Southwestern Medical Center

Sex: All

Age: 18+

Code: NCT06919419

Recruiting

A Study of Raludotatug Deruxtecan With or Without Bevacizumab as First-Line Maintenance Treatment in Non-HRD-Positive Advanced Ovarian Cancer (MK-5909-006, (ENGOT-ov102/GOG-3141/ REJOICE-Ovarian 04)

for
Ovarian Cancer, Ovarian Neoplasms, Peritoneal Cancer,
Location: Fort Worth TX, Tyler TX, Austin TX, Washington D.C. DC,
Sponsor: Merck Sharp & Dohme LLC

Sex: Female

Age: 18+

Code: NCT07776691

Phase 3, Recruiting

Study of BHV-1300 in Graves' Disease

for
Graves Disease
Location: Dallas TX, Houston TX, Shavano Park TX, Memphis TN,
Sponsor: Biohaven Therapeutics Ltd.

Sex: All

Age: 18 - 65

Code: NCT06980649

Phase 1, Recruiting

A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)

for
Cervical Cancer
Location: Fort Worth TX, Tyler TX, Shreveport LA, Tulsa OK,
Sponsor: Merck Sharp & Dohme LLC

Sex: Female

Age: 18+

Code: NCT07216703

Phase 3, Recruiting

A Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

for
Chronic Lymphocytic Leukemia, Lymphoma, Small Lymphocytic
Location: Fort Worth TX, Kyle TX, Mobile AL, Cincinnati OH,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07218341

Phase 4, Recruiting

Efficacy of NBI-1117568 in Preventing Relapse in Adults With Schizophrenia

for
Schizophrenia
Location: DeSoto TX, Flowood MS, Atlanta GA, Tampa FL,
Sponsor: Neurocrine Biosciences

Sex: All

Age: 18 - 65

Code: NCT07227818

Phase 3, Recruiting

Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer

for
Endometrial Cancer
Location: Fort Worth TX, Austin TX, Tulsa OK, San Antonio TX,
Sponsor: Kartos Therapeutics, Inc.

Sex: Female

Age: 18+

Code: NCT05797831

Phase 2, Phase 3, Recruiting

A Study of Dupilumab in Small Children With an Allergic Condition of the Esophagus (Food Pipe): Eosinophilic Esophagitis

for
Eosinophilic Esophagitis (EoE)
Location: Fort Worth TX, Aurora CO, Atlanta GA, Milwaukee WI,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 0 - 6

Code: NCT07112378

Phase 3, Recruiting

Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL

for
Large B-cell Lymphoma
Location: Dallas TX, Tyler TX, Austin TX, Hot Springs AR,
Sponsor: Allogene Therapeutics

Sex: All

Age: 18+

Code: NCT06500273

Phase 2, Recruiting

A Study to Compare Linvoseltamab Monotherapy and Linvoseltamab + Carfilzomib Combination Therapy With Standard-of-Care Combination Regimens in Adult Participants With Relapsed/Refractory Multiple Myeloma (RRMM)

for
Relapsed and/or Refractory Multiple Myeloma (RRMM)
Location: Dallas TX, Houston TX, Atlanta GA, Columbus OH,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07222761

Phase 3, Recruiting

A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)

for
Ovarian Cancer, Fallopian Tube Cancer,
Location: Fort Worth TX, Austin TX, Tulsa OK, San Antonio TX,
Sponsor: Merck Sharp & Dohme LLC

Sex: Female

Age: 18+

Code: NCT06824467

Phase 3, Recruiting

EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors

for
Advanced Solid Tumors, MSI-H or dMMR Advanced Solid Tumors,
Location: Fort Worth TX, Houston TX, Plantation FL, Tamarac FL,
Sponsor: Eikon Therapeutics

Sex: All

Age: 18+

Code: NCT07262619

Phase 1, Phase 2, Recruiting

Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

for
Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome,
Location: Dallas TX, Columbus OH, Portland OR
Sponsor: Jennifer Saultz

Sex: All

Age: 18+

Code: NCT03874052

Phase 1, Recruiting